Literature DB >> 17872702

Do beta-blockers have a role in treating hypertension? Yes.

Nadia Khan1, Finlay A McAlister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17872702      PMCID： PMC1952579     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

1.  Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis.

Authors:  Nadia Khan; Finlay A McAlister
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

2.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Authors:  N A Khan; Finlay A McAlister; Simon W Rabkin; Raj Padwal; Ross D Feldman; Norman Rc Campbell; Lawrence A Leiter; Richard Z Lewanczuk; Ernesto L Schiffrin; Michael D Hill; Malcolm Arnold; Gordon Moe; Tavis S Campbell; Carol Herbert; Alain Milot; James A Stone; Ellen Burgess; B Hemmelgarn; Charlotte Jones; Pierre Larochelle; Richard I Ogilvie; Robyn Houlden; Robert J Herman; Pavel Hamet; George Fodor; George Carruthers; Bruce Culleton; Jacques Dechamplain; George Pylypchuk; Alexander G Logan; Norm Gledhill; Robert Petrella; Sheldon Tobe; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 3.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

4.  Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.

Authors:  K Radack; C Deck
Journal:  Arch Intern Med       Date:  1991-09

Review 5.  Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

Authors:  S Jacob; K Rett; E J Henriksen
Journal:  Am J Hypertens       Date:  1998-10       Impact factor: 2.689

6.  Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Authors:  Jan A Staessen; Ji-Guang Wang; Lutgarde Thijs
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

7.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

Review 8.  Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.

Authors:  Dennis T Ko; Patricia R Hebert; Christopher S Coffey; Artyom Sedrakyan; Jeptha P Curtis; Harlan M Krumholz
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

Review 9.  The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis.

Authors:  Daniela Dobre; Cornelia H M van Jaarsveld; Mike J L deJongste; Flora M Haaijer Ruskamp; Adelita V Ranchor
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-02       Impact factor: 2.890

10.  Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Authors:  F H Messerli; E Grossman; U Goldbourt
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272
  10 in total
  1 in total

1.  Do practice guidelines cause drug shortages? The historical example of β-blockers.

Authors:  Jacalyn Duffin
Journal:  CMAJ       Date:  2019-09-16       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.